Your Health, We Care

Home >Drug List>Selpercatinib>Indications of Selpercatinib

Selpercatinib(Retevmo)

Release date: 2026-01-06 10:27:01     Recommended: 101

Treat non-small cell lung cancer, medullary thyroid carcinoma, and thyroid cancer caused by RET gene mutations.